These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 7751878)

  • 1. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
    DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
    Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
    Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE; Bayerl MG; Bruggeman RD; Mauger D; Ioffreda MD; Abou-Elella A; Helm KF
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomatoid papulosis type A: clinical, morphologic, and immunophenotypic study.
    Sioutos N; Asvesti C; Sivridis E; Aygerinou G; Tsega A; Zakopoulou N; Zographakis I
    Int J Dermatol; 1997 Jul; 36(7):514-7. PubMed ID: 9268749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Chen BJ; Hsieh SM; Hsieh TH; Jhuang JY; Kao YC
    Hum Pathol; 2024 Aug; 150():58-66. PubMed ID: 38971328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC; Yang WI; Lee MG; Kim SN; Cho KH; Lee SJ; Lee MW; Koh JK
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
    Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
    Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.
    Droc C; Cualing HD; Kadin ME
    Cancer Control; 2007 Apr; 14(2):124-32. PubMed ID: 17387297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
    Ferrara G; Ena L; Cota C; Cerroni L
    Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.